• OPEN AN ACCOUNT
Indian Indices
Sensex
83,674.92 -558.72
( -0.66%)
Global Indices
Nasdaq
50,155.23 -53.92
(-0.11%)
Dow Jones
6,964.65 1.84
(0.03%)
Hang Seng
57,686.98 36.44
(0.06%)
Nikkei 225
10,491.19 137.35
(1.33%)
Forex
USD-INR
90.60 -0.06
(-0.06%)
EUR-INR
107.84 0.20
(0.18%)
GBP-INR
123.81 0.16
(0.13%)
JPY-INR
0.58 0.00
(0.79%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
1.0977251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
34.5
62.28
EPS(TTM)
Face Value()
Div & Yield %
0.02
1
0
 

akar auto industries ltd
Texmaco Rail & Engineering bags Rs 7-cr rail electrification order
Dec 18,2025
The contract is to be executed within 12 months from the date of issue of the letter of acceptance.

Texmaco Rail & Engineering (TEXMACO), a listed entity under the Adventz Group, is a prominent player in India’s railway and infrastructure sector. The company operates through three core business segments: Freight Cars, Infra-Rail & Green Energy, and Infra-Electrical. The company specializes in manufacturing rolling stock, locomotive components, hydro-mechanical equipment, railway infrastructure, bridges, and steel structures. It is also a leading supplier of freight cars to Indian Railways.

Texmaco Rail & Engineering’s consolidated net profit slipped 13.73% to Rs 63.92 crore in Q2 FY26, compared to Rs 74.10 crore posted in Q2 FY25. Revenue from operations fell 21.38% year-on-year (YoY) to Rs 1,058.09 crore in the quarter ended 30 September 2025.

Shares of Texmaco Rail & Engineering fell 2.47% to Rs 124.30 on the BSE.